Orthopediatrics Corp (NASDAQ:KIDS) – William Blair issued their Q1 2019 earnings per share estimates for shares of Orthopediatrics in a report issued on Friday. William Blair analyst K. Krum anticipates that the company will earn ($0.08) per share for the quarter. William Blair also issued estimates for Orthopediatrics’ Q2 2019 earnings at ($0.04) EPS, Q3 2019 earnings at $0.01 EPS and Q4 2019 earnings at $0.01 EPS.
A number of other research analysts have also weighed in on the stock. BidaskClub lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. BTIG Research reaffirmed a “buy” rating and issued a $24.00 price target on shares of Orthopediatrics in a research note on Friday, January 5th. Finally, Zacks Investment Research lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Two research analysts have rated the stock with a sell rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $23.67.
A number of institutional investors have recently modified their holdings of the stock. DF Dent & Co. Inc. purchased a new position in Orthopediatrics in the 4th quarter valued at about $1,794,000. TIAA CREF Investment Management LLC purchased a new position in Orthopediatrics in the 4th quarter worth approximately $130,000. Teachers Advisors LLC purchased a new position in Orthopediatrics in the 4th quarter worth approximately $102,000. California State Teachers Retirement System purchased a new position in Orthopediatrics in the 4th quarter worth approximately $141,000. Finally, Deutsche Bank AG purchased a new position in Orthopediatrics in the 4th quarter worth approximately $196,000. 32.54% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: “William Blair Comments on Orthopediatrics Corp’s Q1 2019 Earnings (KIDS)” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/03/13/william-blair-comments-on-orthopediatrics-corps-q1-2019-earnings-kids.html.
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.